BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 29434899)

  • 1. Preclinical study on hypoxic radiosensitizing effects of glycididazole in comparison with those of doranidazole
    Yasui H; Kubota N; Nishizumi J; Sakai Y; Yamamori T; Inanami O
    Oncol Lett; 2018 Feb; 15(2):1993-1998. PubMed ID: 29434899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of hypoxic cell radiosensitizer doranidazole (PR-350) on the radioresponse of murine and human tumor cells in vitro and in vivo.
    Yahiro T; Masui S; Kubota N; Yamada K; Kobayashi A; Kishii K
    J Radiat Res; 2005 Sep; 46(3):363-72. PubMed ID: 16210793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prospective application of a hypoxic radiosensitizer, doranidazole to rat intracranial glioblastoma with blood brain barrier disruption.
    Yasui H; Asanuma T; Kino J; Yamamori T; Meike S; Nagane M; Kubota N; Kuwabara M; Inanami O
    BMC Cancer; 2013 Mar; 13():106. PubMed ID: 23496909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiosensitivity of human pancreatic cancer cells in vitro and in vivo, and the effect of a new hypoxic cell sensitizer, doranidazole.
    Shibamoto Y; Kubota T; Kishii K; Tsujitani M
    Radiother Oncol; 2000 Aug; 56(2):265-70. PubMed ID: 10927148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo efficacy and pharmacokinetics of a new hypoxic cell radiosensitizer doranidazole in SUIT-2 human pancreatic cancer xenografted in mouse pancreas.
    Matsuoka H; Shibamoto Y; Kubota T; Tsujitani M; Majima T
    Oncol Rep; 2000; 7(1):23-6. PubMed ID: 10601585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of a hypoxic cell sensitizer doranidazole on the radiation-induced apoptosis of mouse L5178Y lymphoma cells.
    Aoki M; Furusawa Y; Shibamoto Y; Kobayashi A; Tsujitani M
    J Radiat Res; 2002 Jun; 43(2):161-6. PubMed ID: 12238330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The radiosensitizing effect of doranidazole on human colorectal cancer cells exposed to high doses of irradiation.
    Zhang L; Gong A; Ji J; Wu Y; Zhu X; Lv S; Lv H; Sun X
    BMC Cancer; 2007 Oct; 7():188. PubMed ID: 17919337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced local tumour control after single or fractionated radiation treatment using the hypoxic cell radiosensitizer doranidazole.
    Murata R; Tsujitani M; Horsman MR
    Radiother Oncol; 2008 Jun; 87(3):331-8. PubMed ID: 18375007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation of hypoxia status with radiosensitizing effects of sodium glycididazole: A preclinical study.
    Yu Y; Li X; Xu H; Liu J; Dong M; Yang J; Sun L; Sun X; Xing L
    Oncol Lett; 2018 May; 15(5):6481-6488. PubMed ID: 29616117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced radiosensitizing by sodium glycididazole in a recurrent esophageal carcinoma tumor model.
    Wu P; Liu J; Sun X; Li X; Xing L; Yu J
    Oncotarget; 2017 Sep; 8(38):63871-63880. PubMed ID: 28969036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiation-chemical properties of the hypoxic cell radiosensitizer doranidazole (PR-350).
    Kuwabara M; Iida Y; Inanami O; Sawamura S; Yokoyama K; Tsujitani M
    J Radiat Res; 2002 Mar; 43(1):77-88. PubMed ID: 12056332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase Ia study of a hypoxic cell sensitizer doranidazole (PR-350) in combination with conventional radiotherapy.
    Nemoto K; Shibamoto Y; Ohmagari J; Baba Y; Ebe K; Ariga H; Takai Y; Ouchi A; Sasai K; Shinozaki M; Tsujitani M; Sakaguchi M; Yamada S; Sakamoto K
    Anticancer Drugs; 2001 Jan; 12(1):1-6. PubMed ID: 11272282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo radiosensitizing activity of a new fluorinated hypoxic cell radiosensitizer, KU-2285, in combination with radiation dose fractionation.
    Sasai K; Fushiki M; Yukawa Y; Suyama S; Iwai H; Shibamoto Y; Nishimoto S; Takahashi M; Abe M
    Int J Radiat Oncol Biol Phys; 1991 Oct; 21(5):1231-4. PubMed ID: 1938521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypoxia-responsive block copolymer radiosensitizers as anticancer drug nanocarriers for enhanced chemoradiotherapy of bulky solid tumors.
    Yin W; Qiang M; Ke W; Han Y; Mukerabigwi JF; Ge Z
    Biomaterials; 2018 Oct; 181():360-371. PubMed ID: 30098571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sodium glycididazole enhances the radiosensitivity of laryngeal cancer cells through downregulation of ATM signaling pathway.
    Zeng YC; Xing R; Zeng J; Xue M; Chi F; Xin Y; Fan GL; Wang HM; Duan QY; Sun YN; Niu N; Wu R
    Tumour Biol; 2016 May; 37(5):5869-78. PubMed ID: 26586399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of hypoxic radiosensitizer sodium glycididazole on long-term result of radiotherapy for nasopharyngeal carcinoma].
    Liu MZ; He LR; Lu TX; Chen YY; Hu YH; Cui NJ; Xu GZ; Gao L; Xiao GL; Zhang SW; Cai Y; Li DM; Chen LH; Wang FY; Sun Q; Zhu L; Sheng G; Gao HJ; Bao YH
    Zhonghua Zhong Liu Za Zhi; 2006 Dec; 28(12):932-7. PubMed ID: 17533747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reevaluation of the radiosensitizing effects of sanazole and nimorazole in vitro and in vivo.
    Sugie C; Shibamoto Y; Ito M; Ogino H; Suzuki H; Uto Y; Nagasawa H; Hori H
    J Radiat Res; 2005 Dec; 46(4):453-9. PubMed ID: 16394636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro and in vivo evaluation of novel antitumor prodrugs of 5-fluoro-2'-deoxyuridine activated by hypoxic irradiation.
    Shibamoto Y; Tachi Y; Tanabe K; Hatta H; Nishimoto S
    Int J Radiat Oncol Biol Phys; 2004 Feb; 58(2):397-402. PubMed ID: 14751508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Facile Preparation and Radiotherapy Application of an Amphiphilic Block Copolymer Radiosensitizer.
    Zhao K; Ke W; Yin W; Li J; Qiang M; Ge Z
    ACS Macro Lett; 2017 May; 6(5):556-560. PubMed ID: 35610878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of in vivo efficacy of hypoxic cytotoxin tirapazamine and hypoxic cell radiosensitizer KU-2285 in combination with single and fractionated irradiation.
    Shibata T; Shibamoto Y; Sasai K; Oya N; Murata R; Takagi T; Hiraoka M; Abe M
    Jpn J Cancer Res; 1996 Jan; 87(1):98-104. PubMed ID: 8609056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.